Fieldview Capital Management LLC Purchases New Shares in Cigna Group $CI

Fieldview Capital Management LLC purchased a new position in Cigna Group (NYSE:CI) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 6,094 shares of the health services provider’s stock, valued at approximately $1,757,000.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Harbor Capital Advisors Inc. raised its stake in shares of Cigna Group by 119.5% in the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after acquiring an additional 49 shares during the period. Collier Financial bought a new stake in shares of Cigna Group in the 3rd quarter worth about $34,000. Traub Capital Management LLC purchased a new position in shares of Cigna Group during the 2nd quarter worth about $48,000. Twin Peaks Wealth Advisors LLC bought a new position in Cigna Group during the 2nd quarter valued at about $52,000. Finally, CNB Bank grew its holdings in Cigna Group by 479.4% during the 3rd quarter. CNB Bank now owns 197 shares of the health services provider’s stock valued at $57,000 after purchasing an additional 163 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Price Performance

Shares of CI stock opened at $269.57 on Tuesday. The company has a market capitalization of $71.04 billion, a P/E ratio of 12.15, a P/E/G ratio of 0.94 and a beta of 0.27. The company’s 50-day simple moving average is $280.58 and its two-hundred day simple moving average is $283.75. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company’s revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities analysts anticipate that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be given a dividend of $1.56 per share. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s dividend payout ratio is presently 28.13%.

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the sale, the insider owned 5,670 shares of the company’s stock, valued at $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on CI shares. Mizuho set a $325.00 price objective on shares of Cigna Group in a research note on Friday, January 9th. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Deutsche Bank Aktiengesellschaft raised their price target on Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a research note on Tuesday, February 10th. Jefferies Financial Group boosted their price objective on Cigna Group from $310.00 to $333.00 and gave the company a “buy” rating in a report on Monday, February 9th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cigna Group in a research report on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $330.42.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.